ADORA2A and Alzheimer disease: In addition, A2A adenosine receptor genetic knockdown can ameliorate synaptic damage present in AD models, and numerous studies have found that A2A adenosine receptor antagonists are effective at improving cognition after synaptic loss in AD animal models, providing a way to combat synaptic toxicity [40,52,53,54].